These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14134472)

  • 1. [ACTIVITY OF SOME ANTIMYCOTIC DRUGS ON CANDIDA ALBICANS].
    CIMINO G; ROCCHETTO C
    Boll Ist Sieroter Milan; 1964; 43():29-32. PubMed ID: 14134472
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of triacetin and nystatin with respect to their stability and effect on Candida albicans.
    KUBISTA RA; DERSE PH
    Antibiot Chemother (Northfield); 1959 Sep; 9():546-9. PubMed ID: 14412413
    [No Abstract]   [Full Text] [Related]  

  • 3. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
    Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
    J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
    Braga PC; Maci S; Dal Sasso M; Bohn M
    Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
    Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
    Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECT OF NYSTATIN AND AMPHOTERICIN B ON THE GROWTH OF CANDIDA ALBICANS.
    GHOSH A; GHOSH JJ
    Ann Biochem Exp Med; 1963 Jan; 23():29-44. PubMed ID: 14060842
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonization of voice prostheses by albicans and non-albicans Candida species.
    Bauters TG; Moerman M; Vermeersch H; Nelis HJ
    Laryngoscope; 2002 Apr; 112(4):708-12. PubMed ID: 12152601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans.
    Scheibler E; da Silva RM; Leite CE; Campos MM; Figueiredo MA; Salum FG; Cherubini K
    Arch Oral Biol; 2018 May; 89():70-76. PubMed ID: 29477025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABSORPTION OF AMPHOTERICIN B BY CANDIDA ALBICANS.
    GHOSH A; GHOSH JJ
    Ann Biochem Exp Med; 1963 Dec; 23():603-10. PubMed ID: 14154206
    [No Abstract]   [Full Text] [Related]  

  • 15. Antifungal activity of coronarin D against Candida albicans.
    Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECT OF THIOBENZOATE ON CYTOLOGY OF CANDIDA ALBICANS.
    GALE GR; MCLAIN HH
    J Gen Microbiol; 1964 Aug; 36():297-301. PubMed ID: 14195652
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
    Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
    Mycoses; 2013 Nov; 56(6):672-80. PubMed ID: 23773119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
    Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
    J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.